SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001624422-24-000002
Filing Date
2024-01-19
Accepted
2024-01-19 10:04:34
Documents
3
Period of Report
2024-01-18

Document Format Files

Seq Description Document Type Size
1 6-K phxm_6-kx01182024.htm 6-K 26181
2 EX-99.1 ex-991phxm_6xkx01182024.htm EX-99.1 17878
3 GRAPHIC imagea.jpg GRAPHIC 7189
  Complete submission text file 0001624422-24-000002.txt   55389
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 24544100
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)